Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 61

1.

Widespread correction of central nervous system disease after intracranial gene therapy in a feline model of Sandhoff disease.

McCurdy VJ, Rockwell HE, Arthur JR, Bradbury AM, Johnson AK, Randle AN, Brunson BL, Hwang M, Gray-Edwards HL, Morrison NE, Johnson JA, Baker HJ, Cox NR, Seyfried TN, Sena-Esteves M, Martin DR.

Gene Ther. 2015 Feb;22(2):181-9. doi: 10.1038/gt.2014.108. Epub 2014 Dec 4.

PMID:
25474439
2.

Molecular cloning, sequencing, and distribution of feline GnRH receptor (GnRHR) and resequencing of canine GnRHR.

Samoylov AM, Napier ID, Morrison NE, Martin DR, Cox NR, Samoylova TI.

Theriogenology. 2015 Jan 15;83(2):266-75. doi: 10.1016/j.theriogenology.2014.09.020. Epub 2014 Sep 22.

PMID:
25442384
3.

Sustained normalization of neurological disease after intracranial gene therapy in a feline model.

McCurdy VJ, Johnson AK, Gray-Edwards HL, Randle AN, Brunson BL, Morrison NE, Salibi N, Johnson JA, Hwang M, Beyers RJ, Leroy SG, Maitland S, Denney TS, Cox NR, Baker HJ, Sena-Esteves M, Martin DR.

Sci Transl Med. 2014 Apr 9;6(231):231ra48. doi: 10.1126/scitranslmed.3007733.

4.

Therapeutic response in feline sandhoff disease despite immunity to intracranial gene therapy.

Bradbury AM, Cochran JN, McCurdy VJ, Johnson AK, Brunson BL, Gray-Edwards H, Leroy SG, Hwang M, Randle AN, Jackson LS, Morrison NE, Baek RC, Seyfried TN, Cheng SH, Cox NR, Baker HJ, Cachón-González MB, Cox TM, Sena-Esteves M, Martin DR.

Mol Ther. 2013 Jul;21(7):1306-15. doi: 10.1038/mt.2013.86. Epub 2013 May 21.

5.

Implications of high level pseudogene transcription in Mycobacterium leprae.

Williams DL, Slayden RA, Amin A, Martinez AN, Pittman TL, Mira A, Mitra A, Nagaraja V, Morrison NE, Moraes M, Gillis TP.

BMC Genomics. 2009 Aug 25;10:397. doi: 10.1186/1471-2164-10-397.

6.

Neurodegenerative lysosomal storage disease in European Burmese cats with hexosaminidase beta-subunit deficiency.

Bradbury AM, Morrison NE, Hwang M, Cox NR, Baker HJ, Martin DR.

Mol Genet Metab. 2009 May;97(1):53-9. doi: 10.1016/j.ymgme.2009.01.003. Epub 2009 Feb 23.

PMID:
19231264
7.

Generation and characterization of recombinant feline beta-galactosidase for preclinical enzyme replacement therapy studies in GM1 gangliosidosis.

Samoylova TI, Martin DR, Morrison NE, Hwang M, Cochran AM, Samoylov AM, Baker HJ, Cox NR.

Metab Brain Dis. 2008 Jun;23(2):161-73. doi: 10.1007/s11011-008-9086-5. Epub 2008 Apr 18.

PMID:
18421424
8.

Accelerated detection of Mycobacterium tuberculosis genes essential for bacterial survival in guinea pigs, compared with mice.

Jain SK, Hernandez-Abanto SM, Cheng QJ, Singh P, Ly LH, Klinkenberg LG, Morrison NE, Converse PJ, Nuermberger E, Grosset J, McMurray DN, Karakousis PC, Lamichhane G, Bishai WR.

J Infect Dis. 2007 Jun 1;195(11):1634-42. Epub 2007 Apr 23.

PMID:
17471433
9.

Deletion of a Mycobacterium tuberculosis proteasomal ATPase homologue gene produces a slow-growing strain that persists in host tissues.

Lamichhane G, Raghunand TR, Morrison NE, Woolwine SC, Tyagi S, Kandavelou K, Bishai WR.

J Infect Dis. 2006 Nov 1;194(9):1233-40. Epub 2006 Oct 2.

PMID:
17041849
10.

Peptide phage display: opportunities for development of personalized anti-cancer strategies.

Samoylova TI, Morrison NE, Globa LP, Cox NR.

Anticancer Agents Med Chem. 2006 Jan;6(1):9-17. Review.

PMID:
16475923
11.

Mutation of the GM2 activator protein in a feline model of GM2 gangliosidosis.

Martin DR, Cox NR, Morrison NE, Kennamer DM, Peck SL, Dodson AN, Gentry AS, Griffin B, Rolsma MD, Baker HJ.

Acta Neuropathol. 2005 Nov;110(5):443-50. Epub 2005 Oct 1.

PMID:
16200419
12.

Novel metal clusters isolated from blood are lethal to cancer cells.

Samoylov AM, Samoylova TI, Pustovyy OM, Samoylov AA, Toivio-Kinnucan MA, Morrison NE, Globa LP, Gale WF, Vodyanoy V.

Cells Tissues Organs. 2005;179(3):115-24.

PMID:
15947462
13.
14.

Cell targeted phagemid rescued by preselected landscape phage.

Mount JD, Samoylova TI, Morrison NE, Cox NR, Baker HJ, Petrenko VA.

Gene. 2004 Oct 27;341:59-65.

PMID:
15474288
15.

Phage matrix for isolation of glioma cell membrane proteins.

Samoylova TI, Cox NR, Morrison NE, Globa LP, Romanov V, Baker HJ, Petrenko VA.

Biotechniques. 2004 Aug;37(2):254-60.

16.
17.

Attenuation of late-stage disease in mice infected by the Mycobacterium tuberculosis mutant lacking the SigF alternate sigma factor and identification of SigF-dependent genes by microarray analysis.

Geiman DE, Kaushal D, Ko C, Tyagi S, Manabe YC, Schroeder BG, Fleischmann RD, Morrison NE, Converse PJ, Chen P, Bishai WR.

Infect Immun. 2004 Mar;72(3):1733-45.

18.

Phage probes for malignant glial cells.

Samoylova TI, Petrenko VA, Morrison NE, Globa LP, Baker HJ, Cox NR.

Mol Cancer Ther. 2003 Nov;2(11):1129-37.

19.

Molecular markers of glial tumors: current targeting strategies.

Samoylova TI, Morrison NE, Cox NR.

Curr Med Chem. 2003 May;10(10):831-43. Review.

PMID:
12678686
20.

Influence of dietary calcium and phosphorus content in a fixed ratio on growth and development in Great Danes.

Lauten SD, Cox NR, Brawner WR Jr, Goodman SA, Hathcock JT, Montgomery RD, Kincaid SA, Morrison NE, Spano JS, Lepine AJ, Reinhart GA, Baker HJ.

Am J Vet Res. 2002 Jul;63(7):1036-47.

PMID:
12118666
21.

Targeting peptides for microglia identified via phage display.

Samoylova TI, Ahmed BY, Vodyanoy V, Morrison NE, Samoylov AM, Globa LP, Baker HJ, Cox NR.

J Neuroimmunol. 2002 Jun;127(1-2):13-21.

PMID:
12044970
22.

Body composition of growing and adult cats as measured by use of dual energy X-ray absorptiometry.

Lauten SD, Cox NR, Baker GH, Painter DJ, Morrison NE, Baker HJ.

Comp Med. 2000 Apr;50(2):175-83.

PMID:
10857009
23.

Alterations in the growth hormone/insulin-like growth factor I pathways in feline GM1 gangliosidosis.

Cox NR, Morrison NE, Sartin JL, Buonomo FC, Steele B, Baker HJ.

Endocrinology. 1999 Dec;140(12):5698-704.

PMID:
10579334
24.

Evaluation of GM1 ganglioside-mediated apoptosis in feline thymocytes.

Zhou J, Cox NR, Ewald SJ, Morrison NE, Basker HJ.

Vet Immunol Immunopathol. 1998 Nov 6;66(1):25-42.

PMID:
9847018
25.

Thymic alterations in feline GM1 gangliosidosis.

Cox NR, Ewald SJ, Morrison NE, Gentry AS, Schuler M, Baker HJ.

Vet Immunol Immunopathol. 1998 Jun 12;63(4):335-53.

PMID:
9656423
26.

Effect of locally injected medications on healing of pad wounds in dogs.

Swaim SF, Vaughn DM, Kincaid SA, Morrison NE, Murray SS, Woodhead MA, Hoffman CE, Wright JC, Kammerman JR.

Am J Vet Res. 1996 Mar;57(3):394-9.

PMID:
8669775
27.

Mycobacterium leprae iron nutrition: bacterioferritin, mycobactin, exochelin and intracellular growth.

Morrison NE.

Int J Lepr Other Mycobact Dis. 1995 Mar;63(1):86-91. Review. No abstract available.

PMID:
7730724
28.
29.

Squamous cell carcinomas often produce more than a single bone resorption-stimulating factor: role of interleukin-1 alpha*.

Nowak RA, Morrison NE, Goad DL, Gaffney EV, Tashjian AH Jr.

Endocrinology. 1990 Dec;127(6):3061-9.

PMID:
2174344
30.

The effects of thionapthene-2-carboxylic acid-lysine on the hypercalcemia of malignancy in the rat.

Decker JE, Morrison NE, Lorenzo JA, Samour CM, McCarron BA, Raisz LG.

Calcif Tissue Int. 1989 Jan;44(1):61-4.

PMID:
2521808
31.
32.

Clofazimine analogues active against a clofazimine-resistant organism.

O'Sullivan JF, Conalty ML, Morrison NE.

J Med Chem. 1988 Mar;31(3):567-72.

PMID:
3279207
33.

2-Acetylpyridine thiosemicarbazones and Mycobacterium leprae.

Shepard CC, Klayman DL, Scovill JP, Morrison NE.

Int J Lepr Other Mycobact Dis. 1984 Mar;52(1):7-9.

PMID:
6368429
35.

Correlations between structure and antimycobacterial activity in a series of 2-acetylpyridine thiosemicarbazones.

Collins FM, Klayman DL, Morrison NE.

J Gen Microbiol. 1982 Jun;128(6):1349-56.

PMID:
6811692
36.
37.

Antimycobacterial activity of 2-acetylpyridine thiosemicarbazones in relation to their antileprosy activity.

Morrison NE, Collins FM.

Int J Lepr Other Mycobact Dis. 1981 Jun;49(2):180-6.

PMID:
7196888
38.

Microscopic counts carried out on Mycobacterium leprae and M. tuberculosis suspensions. A comparison of three staining procedures.

Collins FM, Morrison NE, Dhople AM, Watson SR.

Int J Lepr Other Mycobact Dis. 1980 Dec;48(4):402-7.

PMID:
6162812
39.

Abortifacient activity of B1912.

Morrison NE.

Int J Lepr Other Mycobact Dis. 1979 Dec;47(4):613-4. No abstract available.

PMID:
122637
41.
42.

Immune response to persistent mycobacterial infection in mice.

Collins FM, Morrison NE, Montalbine V.

Infect Immun. 1978 May;20(2):430-8.

43.

Comparative DNA binding studies with clofazimine and B1912.

Morrison NE, Marley GM.

Int J Lepr Other Mycobact Dis. 1977 Apr-Jun;45(2):188-9. No abstract available.

PMID:
561764
44.

Clofazimine binding studies with deoxyribonucleic acid.

Morrison NE, Marley GM.

Int J Lepr Other Mycobact Dis. 1976 Oct-Dec;44(4):475-81.

PMID:
798729
45.
47.

The mode of action of clofazimine DNA binding studies.

Morrison NE, Marley GM.

Int J Lepr Other Mycobact Dis. 1976 Jan-Jun;44(1-2):133-4. No abstract available.

PMID:
945233
48.

Growth and immunogenicity of photochromogenic strains of mycobacteria in the footpads of normal mice.

Collins FM, Montalbine V, Morrison NE.

Infect Immun. 1975 May;11(5):1079-87.

49.

Growth of Mycobacterium marinum in the footpads of T-cell-depleted mice.

Collins FM, Montalbine V, Morrison NE.

Infect Immun. 1975 May;11(5):1088-93.

50.

Immunogenicity of an aerogenic BCG vaccine in T-cell-depleted and normal mice.

Morrison NE, Collins FM.

Infect Immun. 1975 May;11(5):1110-21.

Supplemental Content

Loading ...
Support Center